Skip to content

ASP Isotopes, Inc. ASPI Liabilities of discontinued operations (Note 2)

Liabilities of discontinued operations (Note 2) at other companies

Albemarle logo
AlbemarleALB

Other financials

Income statement

See full
Revenue$4.2M+279%
Gross profit$1.7M+409%
Operating income-$24.9M-213%
Net income-$7.1M+15.8%
EPS (diluted)-$0.06+50.0%

Balance sheet

See full
Cash & equivalents$211.7M+278%
Total debt$61.9M+1,787%
Total equity$289.0M+580%
Total assets$587.7M+547%

Cash flow

See full
Operating cash flow-$17.8M-460%
CapEx$6.1M+166%
Free cash flow-$23.9M-336%

Valuation

See full
Market cap$888.88M+40.0%
Enterprise value$739.08M+26.9%
P/S33×-111×

Profitability

See full
Gross margin17.6%-19.8pp
Operating margin-285.4%-102pp
Net margin-588.6%-112pp
FCF margin-244.6%-92.7pp

Returns & leverage

See full
Return on equity-95.6%-19.3pp
Debt / equity0.2×+0.1×
Current ratio4.4×-2.8×

Where this comes from

Reported directly by ASP Isotopes, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent.

The official record: ASP Isotopes, Inc.’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about ASP Isotopes, Inc.'s liabilities of discontinued operations (note 2).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ASP Isotopes, Inc.'s liabilities of discontinued operations (note 2)?
ASP Isotopes, Inc. (ASPI) reported liabilities of discontinued operations (note 2) of $0 in Q1 2026.